immuncell-lc
Cell therapyexperimental
Clinical trial activity
7 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
7
Phase 3
3
Phase 4
0
Earliest trial started Jul 1, 2008 (NCT00699816)
Timeline
Indications
Mechanism of action
- T-lymphocytesImmunity, passive
T-lymphocytes immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- immuncell-lc
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04969731 | Phase 3 | Sep 7, 2021 | Green Cross Corporation, Seoul National University |
| NCT03983967 | Phase 1/Phase 2 (Phase 2) | Jan 24, 2019 | Green Cross Corporation, Seoul National University |
| NCT03220984 | Phase 2 | Mar 16, 2017 | Yonsei University |
| NCT02856815 | Phase 2 | Dec 1, 2016 | Green Cross Corporation, Seoul National University |
| NCT01897610 | Phase 2 | Dec 1, 2013 | Green Cross Corporation, Korea University |
| NCT00807027 | Phase 3 | Dec 1, 2008 | Green Cross Corporation, Hanyang University |
| NCT00699816 | Phase 3 | Jul 1, 2008 | Green Cross Corporation, Seoul National University |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Green Cross Corporation | For profit | 6 | 6 | 2 | 2008 |
| Seoul National University | Academic/Hospital | 4 | 0 | 2 | 2008 |
| Hanyang University | Academic/Hospital | 1 | 0 | 1 | 2008 |
| Korea University | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Yonsei University | Academic/Hospital | 1 | 1 | 1 | 2017 |
5 organizations
Page 1 / 1